Your browser doesn't support javascript.
loading
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer.
Al-Batran, S-E; Pauligk, C; Wirtz, R; Werner, D; Steinmetz, K; Homann, N; Schmalenberg, H; Hofheinz, R-D; Hartmann, J T; Atmaca, A; Altmannsberger, H-M; Jäger, E.
Affiliation
  • Al-Batran SE; Department of Hematology and Oncology, Institute of clinical research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main, Germany. albatran@aol.com
Ann Oncol ; 23(7): 1699-705, 2012 Jul.
Article in En | MEDLINE | ID: mdl-22112973

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Gene Expression / Matrix Metalloproteinase 9 Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Ann Oncol Year: 2012 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Gene Expression / Matrix Metalloproteinase 9 Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Ann Oncol Year: 2012 Document type: Article